Central Ohio Parkinson Society
1380 Dublin Road
PO BOX 16126
Columbus OH 43218-0126
Office: (614) 486-1901
We are a charitable, volunteer, non-profit organization, whose mission is to increase the quality of life of those afflicted with Parkinson's disease, their caregivers, family and others including medical professionals involved in the Parkinson's community. We attempt this goal primarily through education via a monthly newsletter, support group formation and maintenance, distribution of information packets to newly diagnosed Parkinson patients, annual symposia, and ongoing involvement with medical personnel, pharmaceutical professionals, clinical drug trials. We have written and published numerous booklets on various topics relating to Parkinson's. We also provide free speech and exercise classes for Parkinson patients. A recent endeavor of C.O.P.S. has been an increased involvement in writing and financing research grants.
Approximately twenty-two years ago, a group of individuals with a vested interest in Parkinson's disease put together and distributed a free newsletter containing stories, articles from area physicians, and drug information concerning PD. Word of the newsletter spread rapidly and soon it was being sent all over the state of Ohio. We now have a subscriber list of over 2100, and although the majority are in Ohio, we have readers in almost every state in the US (and even a few overseas). Today, our newsletter is regarded as one of the best of its kind in the nation.
We assist over thirty independent support groups by publishing their meeting schedules, providing speakers for their meetings, giving them some financial assistance, computer data support, and informing them of new patients in their area. One of the most important benefits of our support group network is that it allows us to pass on pertinent information in a quick and controlled manner, (a system which works two ways, as medical professionals now have an additional souce of feedback.) This constant flow of information is critical due to the fact that no two Parkinson patients have the same symptoms nor have identical pharmaceutical needs.